Document is current
Any future updates will be listed below
-
Authors
Fleischmann, Roy
Furst, Daniel E.
Connolly-Strong, Erin
Liu, Jingyu
Zhu, Julie
Brasington, Richard
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02919761 at ClinicalTrials.govDocuments that mention this clinical trial
FRI0122 EFFICACY AND PATIENT-REPORTED OUTCOME MEASURES FROM A TWO-PART MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL TRIAL OF REPOSITORY CORTICOTROPIN INJECTION FOR PERSISTENTLY ACTIVE RHEUMATOID ARTHRITIS
https://doi.org/10.1136/annrheumdis-2020-eular.1764
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
https://doi.org/10.1007/s40744-020-00199-3
-
Funding
Funding for this research was provided by:
Mallinckrodt Pharmaceuticals
- License Information
-
More Information
Article History
Received: 31 January 2020
First Online: 17 March 2020
